Atai Beckley N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Atai Beckley N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
/ 
Frequently asked questions
To buy Atai Beckley N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Atai Beckley N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Atai Beckley N.V. is ATAI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Atai Beckley N.V. has its primary listing on NASDAQ. You can trade Atai Beckley N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Atai Beckley N.V. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Atai Beckley N.V. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Atai Beckley N.V..